1.0(top 50%)
impact factor
21.3K(top 1%)
papers
55.9K(top 5%)
citations
68(top 10%)
h-index
1.1(top 50%)
impact factor
24.7K
all documents
63.6K
doc citations
103(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016Open Forum Infectious Diseases2019456
2Weight Gain After Fecal Microbiota TransplantationOpen Forum Infectious Diseases2015336
3High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019Open Forum Infectious Diseases2020327
4Treatment Options for Carbapenem-Resistant Enterobacteriaceae InfectionsOpen Forum Infectious Diseases2015315
5Increasing Infectious Endocarditis Admissions Among Young People Who Inject DrugsOpen Forum Infectious Diseases2016292
6Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations AuditOpen Forum Infectious Diseases2018255
7Coronavirus Disease 2019 Treatment: A Review of Early and Emerging OptionsOpen Forum Infectious Diseases2020255
8A Review of the Global Burden, New Diagnostics, and Current Therapeutics for AmebiasisOpen Forum Infectious Diseases2018228
9Rates of Pneumococcal Disease in Adults With Chronic Medical ConditionsOpen Forum Infectious Diseases2014202
10C-Reactive Protein Level May Predict the Risk of COVID-19 AggravationOpen Forum Infectious Diseases2020194
11Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United StatesOpen Forum Infectious Diseases2020185
12Acute Phase Reactants in Infections: Evidence-Based Review and a Guide for CliniciansOpen Forum Infectious Diseases2015178
13The Increase in Hospitalizations for Urinary Tract Infections and the Associated Costs in the United States, 1998–2011Open Forum Infectious Diseases2017176
14Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site InfectionOpen Forum Infectious Diseases2018167
15Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)Open Forum Infectious Diseases2020160
16Monkeypox: A Contemporary Review for Healthcare ProfessionalsOpen Forum Infectious Diseases2022156
17Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysisOpen Forum Infectious Diseases2018143
18An “Infodemic”: Leveraging High-Volume Twitter Data to Understand Early Public Sentiment for the Coronavirus Disease 2019 OutbreakOpen Forum Infectious Diseases2020141
19Vaccine Rejection and Hesitancy: A Review and Call to ActionOpen Forum Infectious Diseases2017139
20Hope on the Horizon: Novel Fungal Treatments in DevelopmentOpen Forum Infectious Diseases2020139
21Normal Body Temperature: A Systematic ReviewOpen Forum Infectious Diseases2019138
22Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)Open Forum Infectious Diseases2019136
23Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008–2014Open Forum Infectious Diseases2015135
24Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and SafetyOpen Forum Infectious Diseases2019133
25Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance ProgramOpen Forum Infectious Diseases2019132
26Epidemiology and Clinical Features of Invasive Fungal Infection in a US Health Care NetworkOpen Forum Infectious Diseases2018130
27Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19Open Forum Infectious Diseases2021130
28Postacute COVID-19: An Overview and Approach to ClassificationOpen Forum Infectious Diseases2020128
29Long COVID and Post-infective Fatigue Syndrome: A ReviewOpen Forum Infectious Diseases2021128
30Adenosine Analog NITD008 Is a Potent Inhibitor of Zika VirusOpen Forum Infectious Diseases2016124
31Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance ProgramOpen Forum Infectious Diseases2019124
32Risk Factors for Herpes Zoster Infection: A Meta-AnalysisOpen Forum Infectious Diseases2020124
33Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1Open Forum Infectious Diseases2015119
34Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosaOpen Forum Infectious Diseases2017113
35Invasive Aspergillosis Associated With Severe Influenza InfectionsOpen Forum Infectious Diseases2016108
36Infectious Complications of Multiple Sclerosis Therapies: Implications for Screening, Prophylaxis, and ManagementOpen Forum Infectious Diseases2018107
37Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of LiteratureOpen Forum Infectious Diseases2017103
38Serum Iron Level as a Potential Predictor of Coronavirus Disease 2019 Severity and Mortality: A Retrospective StudyOpen Forum Infectious Diseases2020102
39Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019Open Forum Infectious Diseases2020101
40Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 PneumoniaOpen Forum Infectious Diseases2020101
41Host Characteristics and Bacterial Traits Predict Experimental Virulence for Escherichia coli Bloodstream Isolates From Patients With UrosepsisOpen Forum Infectious Diseases2015100
42Outpatient Parenteral Antimicrobial Therapy Among People Who Inject Drugs: A Review of the LiteratureOpen Forum Infectious Diseases2018100
43Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking EraOpen Forum Infectious Diseases202199
44Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19Open Forum Infectious Diseases202097
45Risk of Tuberculosis Infection and Disease for Health Care Workers: An Updated Meta-AnalysisOpen Forum Infectious Diseases201795
46Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II TrialOpen Forum Infectious Diseases201592
47Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated InfectionsOpen Forum Infectious Diseases202192
48Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter StudyOpen Forum Infectious Diseases202191
49Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort StudyOpen Forum Infectious Diseases201789
50Automated Outbreak Detection of Hospital-Associated InfectionsOpen Forum Infectious Diseases201586